K

Korean Drug Co Ltd
KOSDAQ:014570

Watchlist Manager
Korean Drug Co Ltd
KOSDAQ:014570
Watchlist
Price: 4 160 KRW 1.34% Market Closed
Market Cap: ₩45.8B

Net Margin

4.4%
Current
Improving
by 1%
vs 3-y average of 3.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.4%
=
Net Income
₩2.8B
/
Revenue
₩62.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.4%
=
Net Income
₩2.8B
/
Revenue
₩62.2B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Korean Drug Co Ltd
KOSDAQ:014570
45B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
64th
Based on 2 632 companies
64th percentile
4.4%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Korean Drug Co Ltd
Glance View

Market Cap
45.8B KRW
Industry
Pharmaceuticals

KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Korean Drug Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
4.4%
=
Net Income
₩2.8B
/
Revenue
₩62.2B
What is Korean Drug Co Ltd's current Net Margin?

The current Net Margin for Korean Drug Co Ltd is 4.4%, which is above its 3-year median of 3.4%.

How has Net Margin changed over time?

Over the last 3 years, Korean Drug Co Ltd’s Net Margin has decreased from 14.6% to 4.4%. During this period, it reached a low of -6.6% on Mar 31, 2024 and a high of 15.6% on Mar 31, 2023.

Back to Top